Joy Manning

DocwireNews

A newly identified pattern of nonscarring alopecia, termed macular alopecia, may represent an underrecognized clinical entity, according to findings from a single-center, retrospective chart review. The research was conducted at a pediatric dermatology clinic between February 2011 and February 2024. The results were <a href="https://pubmed.ncbi.nlm.nih.gov/40289560/">published</a> in Pediatric Dermatology.Investigators reviewed 471 cases of hair loss, ultimately categorizing 397 patients as having patchy alopecia areata (AA) and 74 patients as having macular alopecia, defined by lesions less than 1 cm in diameter.Compared with patients with patchy AA, those with macular alopecia were more likely to be female (77%) and Hispanic/Latinx (62%) and had a younger median age at onset (5.9 years). Macular alopecia lesions were predominantly located on the parietal scalp, whereas patchy AA lesions were more common on the occipital scalp.Follow-up data revealed that macular alopecia had a significantly higher spontaneous resolution rate without recurrence (63%) compared with patchy AA (20%). The median time to resolution was shorter for macular alopecia (5.0 months) than for patchy AA (8.0 months).The authors propose the term macular alopecia to distinguish this presentation from other established patterns of AA. This study highlights the importance of recognizing macular alopecia as a distinct clinical pattern with a favorable prognosis.Source:Thapar M, et al. Pediatr Dermatol. 2025. doi:<a href="https://doi.org/10.1111/pde.15946">10.1111/pde.15946</a>

Jordana Jampel

Modernization and the Rising Burden of IBD: New Insights From a Global Study

Gastroenterology

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Latest News

Researchers Define Macular Alopecia as Distinct Entity With High Rates of Spontaneous Recovery

Dermatology

A new pattern of nonscarring alopecia, termed macular alopecia, may represent an underrecognized clinical entity.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe